← All drugs Report issue

syha1813

Small moleculeexperimental

Clinical trial activity

3 trials · 0 clinical orgs · 0 marketing orgs

Phase 1

2

Phase 2

2

Phase 3

0

Phase 4

0

Earliest trial started Dec 12, 2023 (NCT06157918)

Timeline

No events for the selected filters.

Indications

Studied for

Mechanism of action

Vascular endothelial growth factor receptor 3INHIBITOR
FLT4 inhibitor
- Vascular endothelial growth factor receptor 3 (FLT4) ↗
Vascular endothelial growth factor receptor 2INHIBITOR
KDR inhibitor
- Vascular endothelial growth factor receptor 2 (KDR) ↗
Vascular endothelial growth factor receptor 1INHIBITOR
FLT1 inhibitor
- Vascular endothelial growth factor receptor 1 (FLT1) ↗
Macrophage colony stimulating factor receptorINHIBITOR
CSF1R inhibitor
- Macrophage colony-stimulating factor 1 receptor (CSF1R) ↗

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT ID	Phase	Start date	Sponsor(s)
NCT06739213	Phase 2	Jan 31, 2025	—
NCT06682611	Phase 1/Phase 2 (Phase 2)	Nov 13, 2024	—
NCT06157918	Phase 1	Dec 12, 2023	—

Showing 3 of 3 trials

Page 1 / 1